CAMS 2021 Scientific Conference: Looking Back, Looking Forward: Preparing for the Post-Pandemic World

PROGRAM FACULTY


Helen Y. Chu, MD, MPH

Associate Professor of Medicine and Epidemiology

University of Washington

Dr. Chu is Associate Professor at the University of Washington Schools of Medicine and Public Health, and an expert on respiratory viruses and vaccines. She has made substantial contributions to the COVID response in Washington State.  Along with a team of scientists, she leads the Seattle Flu Study, a study focused on pandemic preparedness which first identified COVID-19 community transmission in the United States. She established the first cohort of COVID-19 survivors in the United States, which allowed for major early contributions to development of treatments and vaccines for SARS-CoV-2. She has worked closely with local public schools in Snohomish, Seattle, and Yakima to do studies in young children to understand testing and school-based transmission, and has led the Husky Coronavirus Testing program, the testing program for University of Washington students, faculty, and staff. She has also worked with multiple other underserved populations including the homeless populations in Seattle. She serves on the NIH Expert Working Groups for Maternal COVID Vaccines, COVID, and Respiratory Viruses. As an acknowledgment of her contribution to the state-wide COVID response, she received the Researcher of the Year Award from the Puget Sound Business Journal, the SHERO award from the National Organization for Women, the UW School of Public Health Changemakers Award, the Seattle Mariners Hometown Hero Award, the Seattle Seahawks 12 Flag Raiser, and the Washingtonian of the Year Award from the State of Washington.  



XinQi Dong, MD, MPH

Director, Institute for Health, Health Care Policy and Aging Research

Henry Rutgers Distinguished Professor of Population Health Sciences

Rutgers University-New Brunswick

Professor XinQi Dong is director of the Institute for Health, Health Care Policy, and Aging Research (IFH) at Rutgers as well as the inaugural Henry Rutgers Distinguished Professor of Population Health Sciences. Professor Dong has published extensively on the topic of violence prevention with more than 200 peer-reviewed publications and is leading a longitudinal epidemiological study (The PINE Study) of 3,300 Chinese older adults to quantify relationships among culture, violence, and health outcomes.

Professor Dong was appointed a member of the Institute of Medicine’s Global Violence Prevention Forum and then chaired the workshop on elder abuse prevention. An epidemiologist and health services researcher whose research focuses on aging populations and the intersection of culture, resilience, and health outcomes, Professor Dong has been a strong advocate for advancing health issues in underrepresented communities worldwide.



Victor J. Dzau, MD

President, National Academy of Medicine

Vice Chair, National Research Council

Victor J. Dzau, MD is the President of the National Academy of Medicine (NAM), formerly the Institute of Medicine (IOM), US. In addition, he serves as Vice Chair of the National Research Council.  

Dr. Dzau has made a significant impact on health and medicine through his seminal research in cardiovascular medicine and genetics and his leadership in health innovation. His important work on the renin angiotensin system (RAS) paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as widely used, lifesaving drugs. His pioneering research in cardiovascular regeneration led to the Paracrine Hypothesis of stem cell action and the strategy of direct cardiac reprogramming. In his role as a leader in health, Dr. Dzau has led efforts in innovation to improve health, including the founding of the Harvard BWH Division of Global Equity, the International Partnership in Innovation in Healthcare, the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke-National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation, and recently participated in the founding of the Coalition for Epidemic Preparedness and Innovation.

Since arriving at the National Academies, Dr Dzau has emphasized leadership, innovation, and impact. He has led important initiatives such as the Global Health Risk Framework for the Future, the Human Gene Editing Initiative, Vital Directions for Health and Healthcare, and Grand Challenges in Health and Medicine. His vision is to advance science, medicine, and policy to improve health globally.


Hanson Hsu, MD


Physician IT Liaison, NewYork-Presbyterian

Attending Physician, Department of Emergency Medicine, NYP-WCMC

Assistant Professor, Clinical Emergency Medicine, Weill Cornell Medical College


Dr. Hsu has been instrumental in promoting and adapting telehealth during the

COVID-19 pandemic within New York Presbyterian and Weill Cornell Medical Center.


Shari M. Ling, MD

Deputy Chief Medical Officer

Centers for Medicare and Medicaid Services

Center for Clinical Standards and Quality


Kathleen Otte


New York Regional Administrator

Centers for Medicare & Medicaid Services


As Regional Administrator and Staff Director for CMS New York, Kathleen Otte leads and

coordinates local external engagement efforts with all regional stakeholders and customers in New

Jersey and New York. She also provides administrative and operational support to all employees

in CMS New York, promoting cohesion and collaboration throughout the regional office and with

other CMS components. Manage, oversee, and coordinate space and facility operations for all staff

assigned to the New York Regional Office. Serve as CMS' primary official for New York and New

Jersey. Responds to requests for information, media interviews and coordination with other CMS

components. Develop and foster collaborative partnerships and engagement opportunities with

stakeholders that enhance policy, operations, and other enterprise interests/initiatives designed to

enhance health care quality, value, and access to coverage. Develop and set the internal

agenda/strategy and plan for building and assuring external public campaign operations and

messaging for various outreach and awareness campaigns at the regional and local levels.

Strengthen engagement and partnerships with a variety of CMS stakeholders while promoting

awareness of all CMS programs through outreach and education.




Litjen (L.J.) Tan, MS, PhD

Chief Strategy Officer, Immunization Action Coalition

Co-Chair, National Adult Immunization Summit and National Influenza Vaccine Summit


Prior to joining the Immunization Action Coalition (IAC), Dr. Tan was the director of medicine and public health at the American Medical Association (AMA) a position he held since 2008. From 1997 to 2008, he was the AMA's director of infectious disease, immunology, and molecular medicine.

Dr. Tan was a voting member of the Department of Health and Human Services' National Vaccine Advisory Committee from 2009 to 2013, where he served on the adult immunization, vaccine safety, and healthcare worker immunization working groups, and chaired the immunization infrastructure working group. For more than ten years, he was the AMA's liaison to the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, where he served on the influenza, pneumococcal, zoster, and adult immunization working groups.

He co-founded and currently co-chairs the National Adult and Influenza Immunization Summit. He serves or has served on the steering committees/advisory boards of the 317 Coalition, the Adult Vaccine Access Coalition (AVAC), the Unity (United for Adolescent Vaccination) Consortium, the National Network for Immunization Information, and the National Viral Hepatitis Roundtable and on the IAC scientific advisory board. Dr. Tan has also serves, or has served, on the National Quality Forum's Adult Immunizations Expert Committee, the Pharmacy Quality Alliance's Adult Immunization Working Group, and numerous national and international expert and technical advisory committees, including panels for the Centers for Medicare and Medicaid Services, The Joint Commission, and the Centers for Disease Control and Prevention, on issues ranging from vaccine hesitancy, immunization quality measurement development, adult immunizations, to immunization access and delivery. In 2007, he founded the National Immunization Congress and organized its 2007 and 2010 meetings.

Dr. Tan received his Master of Science degree in biology at New York University and earned his PhD in microbiology/immunology from Northwestern University Feinberg School of Medicine in Chicago. Dr. Tan is an editor for Vaccine, BMC Infectious Diseases, Medscape Infectious Diseases, and a member of the ESCMID Vaccine Study Group and has published more than 50 peer-reviewed articles. During his tenure at the AMA, he wrote numerous scientific reports to guide the association's policies on a diverse range of public health topics. A skilled and sought-after speaker, Dr. Tan has been invited to address international, national, and state immunization audiences on issues ranging from vaccine financing to risk management in vaccine safety to emerging infectious diseases.

Dr. Tan has received several awards for his advocacy work including the 2011 CDC National Center for Immunization and Respiratory Diseases Honor Awards: Excellence in Partnering recognition, and most recently was awarded the American Pharmacists Association's national Friend of Pharmacy Award. As a former part-time faculty member at the Institute for Science Education and Science Communication, Columbia College, Chicago, he received the 2000 Excellence in Teaching Award.


Winston F. Wong, MD, MS

Chair, National Council of Asian Pacific Islander Physicians

Scholar-in-Residence, UCLA Kaiser Permanente Center for Health Equity


Winston Wong, MD, MS, FAAFP, is a Scholar in Residence at the UCLA Kaiser Permanente

Center for Health Equity at the Fielding School of Public Health, UCLA. A fellow of the

American Academy of Family Practice, Dr. Wong’s professional career has encompassed

leadership roles at community health centers, federal service and most recently at Kaiser

Permanente, where he served as Medical Director for Community Benefit for over 17 years. His

commitment to addressing health equity is anchored by his experience as a bilingual primary

care community health center physician for the Asian immigrant community in Oakland

Chinatown, which led him to leadership roles in the United States Public Health Service, where

he served as HRSA’s chief Clinical Officer for a region than spanned the Pacific and western

United States. At Kaiser Permanente, he was responsible for its national philanthropic

strategies to support clinical and population management initiatives with the safety net, and for

its quality initiatives to address disparities within its 12 million membership. In 2016 he was

appointed to the US DHHS Advisory Committee on Minority Health, and in 2019 was appointed

chair. At the NASEM he chairs the Roundtable on Health Equity, and has served on the Board

of Population Health and Public Health Practice. As a leader in philanthropy, he has active

Board roles at the California Endowment and Grantmakers in Health. He also previously served

as Board Chair for the School Based Health Alliance and is the current acting CEO and Chair of

the National Council of Asian Pacific Islander Physicians. His work in developing programs and

policies to address health equity has been recognized by awards from the California Primary

Care Association, Latino Health Access, the Minority Health Foundation, Asian Health Services,

and Congresswoman Barbara Lee. In addition to his 2020 Scholar in Residence appointment at

UCLA, Dr. Wong received a Doctor or Humane Letters from the A.T. Still of Osteopathic

Medicine.

RESEARCH PRESENTERS


Michael Chang

Michael Chang is a fourth-year medical student at Harvard Medical School, with plans to pursue residency training in dermatology. He graduated from Princeton University with a Bachelor's in Molecular Biology. Under the mentorship of Dr. Rebecca Hartman, he has conducted dermatoepidemiological research at the Brigham and Women's Hospital/Dana-Farber Cancer Institute and the VA Boston Healthcare System. Michael is passionate about pursuing a future career focused on cutaneous oncology and health disparities research.

Powered by Wild Apricot Membership Software